Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer
- Conditions
- Bladder Cancer
- Registration Number
- NCT06009510
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
The study seeks to delve into the firsthand experiences of patients diagnosed with bladder cancer who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals.
By joining this clinical trial, individuals have the unique opportunity to contribute to the betterment of future bladder cancer patients and play an active role in advancing medical research.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
- Patient has self-identified as planning to enroll in a clinical trial
- Patient has been diagnosed with bladder cancer
- Patient is a minimum of 18 years or older
- Patient does not understand, sign, and return consent form
- Inability to perform regular electronic reporting
- Patient is pregnant
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of patients who decide to participate in a bladder cancer clinical research 3 months Rate of patients who remain in bladder cancer clinical research to trial completion 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States